RESEARCH INTERESTS
Pharmacologist by background with a keen interested in characterising the relationship between drug exposure and effect. These so called pharmacokinetic-pharmacodynamic relationships can be used to optimise dosing regimens and design prospective clinical trials.

My research portfolio currently comprises three main themes:
1. Exploring candidate biomarkers for treatment response in active pulmonary tuberculosis patients.
2. Investigating emergence of phenotypic mycobacterial sub-populations.
3. Aggregating a centralised and standardised quantitative pharmacokinetic database, using Natural Language Processing, to make it amenable to the application of machine learning.